We encourage patients to have thorough discussions with their healthcare providers, addressing: Individual risk factors for vision problems Potential benefits of semaglutide for diabetes management or weight loss Alternative treatment options Monitoring strategies to detect early signs of eye complications For some patients, the benefits of improved blood sugar control or significant weight loss may outweigh the potential vision risks
In the OASIS 4 trial, the pill produced an average weight loss of 13.6% over 64 weeks, comparable to injectable Wegovy 2.4 mg
A baby who nurses once daily and eats solid foods for the other meals has minimal breast milk exposure
Additionally, the phenomenon of "Ozempic face" has emerged, highlighting the distressing facial changes that accompany the rapid and extensive weight loss induced by these medications
Combining both allows for acute therapeutic effects from injectables with baseline support from oral forms
Calcitonin receptor neurons in the mouse nucleus tractus solitarius control energy balance via the non-aversive suppression of feeding